Chitra Venugopal
Hamilton, ON L8S4L8, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 113 publications
Selectively targeting inosine monophosphate dehydrogenase-2 impairs brain metastatic potential while preserving immune cell function.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: June 17, 2026
uPAR is highly expressed in recurrent glioblastoma and represents a candidate CAR T cell target.
Journal: Science translational medicine
Published: May 13, 2026
Emerging paradigms in the study of brain metastases.
Journal: Science signaling
Published: April 07, 2026
Are the current preclinical models adequate to evaluate CAR-T cell therapy in pediatric high-grade gliomas?
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: March 12, 2026
TP63 expression correlates with mesenchymal-like gene signature in patient-derived recurrent glioblastoma cells.
Journal: Biochemical and biophysical research communications
Published: February 23, 2026
Glioblastoma cells that evade chemoradiotherapy-induced cell death exhibit a bifurcated glycolytic program.
Journal: Cell death & disease
Published: November 02, 2025
Targeting SRC enhances differentiation and promotes multifaceted cell death mechanisms in recurrent group 3 medulloblastoma.
Journal: Cell death & disease
Published: August 29, 2025
Generation of Allogeneic CAR-T Circumvents Functional Deficits in Patient-Derived Autologous Product for Glioblastoma.
Journal: International journal of cancer
Published: August 05, 2025
Crossing Barriers: In Vitro Cancer Model for Studying Monocyte Migration across Endothelial Barriers.
Journal: ACS biomaterials science & engineering
Published: July 17, 2025
A genome-wide in vivo CRISPR activation screen identifies BACE1 as a therapeutic vulnerability of lung cancer brain metastasis.
Journal: Science translational medicine
Published: July 02, 2025
Last Updated: 09/26/2026